Cristopher John Wraight

Title: Cristopher John Wraight: Innovator in Growth Factor Modulation

Introduction

Cristopher John Wraight is a notable inventor based in Blackburn, Australia. He has made significant contributions to the field of biotechnology, particularly in the modulation of insulin-like growth factor I receptor expression. His work has implications for treating various proliferative and inflammatory conditions.

Latest Patents

Wraight holds a patent for the invention titled "Modulation of insulin like growth factor I receptor expression." This invention provides compositions and methods for modulating the expression of growth factor genes. Specifically, it relates to compounds, particularly oligonucleotide compounds, that hybridize with nucleic acid molecules encoding the Insulin Like Growth Factor I receptor (IGF-I receptor or IGF-IR), especially in humans. The compounds exemplified in this patent are designed to modulate proliferation, which is relevant to the treatment of proliferative and inflammatory skin disorders and cancer. However, these compounds can also be utilized for any other condition involving the IGF-IR, including inflammatory conditions. Wraight has 1 patent to his name.

Career Highlights

Cristopher John Wraight has been associated with Antisense Therapeutics Limited, where he has contributed to innovative research and development in the field of gene modulation. His work has been pivotal in advancing therapeutic options for various medical conditions.

Collaborations

Wraight has collaborated with notable professionals in his field, including George Arthur Werther and Nicholas M Dean. These collaborations have further enhanced the impact of his research and inventions.

Conclusion

Cristopher John Wraight is a distinguished inventor whose work in modulating insulin-like growth factor I receptor expression has the potential to transform treatment approaches for several medical conditions. His contributions to biotechnology continue to pave the way for future innovations.